Abstract: The invention is directed to a method for the preparation of a multiring engineered heart tissue construct suitable for use in cardiac tissue augmentation and/or replacement therapy. The invention further refers to multiring EHT constructs which comprise at least two force-generating engineered heart tissue rings fused with each other and a device for preparing the same. Finally, the invention relates to force-generating engineered heart tissue rings derived from human cells and their use in drug screening and target validation assays.
Type:
Grant
Filed:
November 6, 2019
Date of Patent:
January 19, 2021
Assignee:
Tissue Systems Holding GmbH
Inventors:
Wolfram-Hubertus Zimmermann, Thomas Eschenhagen
Abstract: The invention is directed to a method for the preparation of a multiring engineered heart tissue construct suitable for use in cardiac tissue augmentation and/or replacement therapy. The invention further refers to multiring EHT constructs which comprise at least two force-generating engineered heart tissue rings fused with each other and a device for preparing the same. Finally, the invention relates to force-generating engineered heart tissue rings derived human cells and their use in drug screening and target validation assays.
Type:
Grant
Filed:
March 26, 2018
Date of Patent:
December 3, 2019
Assignee:
Tissue Systems Holding GmbH
Inventors:
Wolfram-Hubertus Zimmermann, Thomas Eschenhagen